Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
August 2009
New data published in the Journal of the American Medical Association show a steady decline in hip fractures in Canada from 1985 through 2005. While the absolute number of fractures increased over that period based on the increasing elderly population,... more
Earnings Corin reported 1H:09 sales of GBP 20.1 million ($33.0 million), down 25% over 1H:08 after adjusting for currency and beating estimates by GBP 2.1 million ($3.5 million). Outside the U.S., revenues increased by 10%, which the company attributed to... more
Last week's $75 million private placement in Arthrocare (ARTC.PK) was not a one off event. It was more like a sign of the times. Private placements are investments in a company where the investor is a small group of chosen... more
Medtronic announced their FQ1:10 results on Tuesday, which included $915 million in spine revenues. This reflects an 8% (constant currency) increase over the year-ago period, though it should be noted that Medtronic had about an extra week of selling days... more
Scientists at the University of Utah have uncovered a way to produce a synthetic adhesive based on a natural glue created by the sandcastle worm. This ocean worm builds its home by sticking pieces of sand and shells together, and... more
Earnings aap Implantate reported 1H:09 sales of EUR 14.7 million ($20.7 million), representing a 10% decreased from 1H:08. Adjusting for one-time income, sales were down 3%, and in the second half of 2009, the company "anticipates a recovery in demand... more
An FDA panel determined in a 6-1 vote that Q-Med's single-injection Durolane, a hyaluronic acid, should not receive market approval. The panel raised efficacy concerns based on study data showing limited benefit for the product compared to placebo. The panel... more
An FDA panel unanimously determined on Tuesday that DePuy's ceramic-on-metal hip, the Pinnacle CoMplete, is safe and effective, essentially recommending it for market approval. The panel also recommended modifying the labeling and undertaking a post-market study as conditions for approval.... more
Researchers have identified a protein marker that predicts the onset of severe OA, according to a study published in the journal Arthritis & Rheumatism. Seeking an OA predictor apart from age and weight, scientists focused on vascular cell adhesion molecule... more
According to a study published in the Canadian Medical Association Journal, patients 50 and older who suffer vertebral and hip fractures may also have an increased risk of mortality. Results showed that 16% of people who develop a vertebral fracture... more
FDA's director of the Center for Devices and Radiological Health, Dr. Daniel Schultz, is resigning his post following a "mutual agreement" with FDA commissioner Margaret Hamburg. The news follows complaints from critics that Schultz's oversight of the device industry may... more
Researchers in Japan have successfully used stem cells to grow a tooth in a mouse model in what the Wall Street Journal calls "the first time scientists have developed a fully functioning three-dimensional organ replacement." The replacement tooth's structure, hardness... more
Earnings BioMimetic Therapeutics reported 2Q:09 royalty and sublicense revenue of $0.4 million, missing estimates by $0.1 million. The company reported a net loss of $6.3 million, or $0.32 per share, beating estimates by $0.17. Among the highlights for the quarter... more
As part of our collaboration with ArgoSpine, we're republishing select content from the ArgoSpine News and Journal for our audience. The article below, written by Evalina Burger of the Spine Center at the University of Colorado Hospital, was first published... more
Patients who receive cervical fusion or disc arthroplasty to treat radiculopathy or myelopathy may also experience a reduction in associated headaches, according to a new study published in JBJS. Researchers analyzed data from roughly 1,000 patients participating in the Prestige... more
Two studies published this week in the New England Journal of Medicine cast doubts over the efficacy of vertebroplasty. The first study, conducted in Australia, randomized 78 patients in a multicenter, double-blind, placebo-controlled trial in which participants with one or... more
Earnings Alphatec Spine, Inc. announced financial results for FQ2:09. Consolidated revenues for the second quarter 2009 were $32.3 million, an increase of 35% from 2Q:08 and an increase of 5% over first quarter 2009. Adjusted EBITDA reached $2.8 million in... more
Osiris Therapeutics has been at the forefront of developing stem-cell-based products in orthopedics, most notably with their commercialization of Osteocel. That product line was sold to NuVasive last year, leaving Orthofix (who had previously distributed Osteocel under the name Trinity)... more
While President Obama missed his target of passing healthcare legislation this summer, reform is certainly moving ahead. A House bill overhauling the U.S. healthcare system will receive a floor vote after the August recess, progress that follows a 31-28 positive... more
Late Friday afternoon, CMS issued their final rule for FY2010 for inpatient reimbursement rates. When we reviewed specific areas of spine, the rule turned out to be a boost compared to their April proposal. Spine reimbursement rates were finalized at... more
Complete Archive
|
